Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Leases: 2022-2023

  • Lexeo Therapeutics' Leases was N/A to $9.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $10.7 million for FY2022, which is N/A change from last year.
  • Lexeo Therapeutics' Leases amounted to $9.8 million in Q3 2023, which was down 8.70% from $10.7 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Leases ranged from a high of $10.7 million in Q4 2022 and a low of $9.8 million during Q3 2023.
  • Over the past 2 years, Lexeo Therapeutics' median Leases value was $10.2 million (recorded in 2022), while the average stood at $10.2 million.